Soo-Chan Kim
0000-0002-2327-4755
5 papers found
Refreshing results…
Efficacy of oral JAK1 or JAK1/2 inhibitor for treating refractory pruritus in dystrophic epidermolysis bullosa: A retrospective case series
Two cases of KRT1 mutation‐associated epidermolytic ichthyosis without typical epidermolytic hyperkeratosis in the neonatal skin lesions
Clinical effect of omalizumab as an adjuvant treatment to rituximab in patient with refractory bullous pemphigoid
How Do Experts Treat Patients with Bullous Pemphigoid around the World? An International Survey
Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1–high T cells
Missing publications? Search for publications with a matching author name.